Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of Physical and Rehabilitation Medicine|March 6, 2017
No beneficial effect of bracing after anterior cruciate ligament reconstruction in a cohort of 969 athletes followed in rehabilitationP Bordes, E Laboute, A Bertolotti, et al.
Epidemiology and Infection|March 1, 2018
Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion islandA Duvignaud, A Fianu, A Bertolotti, et al.
Journal of Biomedical Materials Research. Part A|June 21, 2007
Surface properties and implantation site affect the capsular fibrotic overgrowthG J Bakeine, A Bertolotti, M Latina, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 28, 2009
Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastasesG J Bakeine, M Di Salvo, S Bortolussi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantationM Diez, L Favaloro, A Bertolotti, et al.
NPJ Breast Cancer|December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapyS Pizzamiglio, A Blanda, V Appierto, et al.
Transplantation Proceedings|August 19, 2014
Short- and long-term outcomes of every graft recovered during a multi-organ procurement procedure including the intestineP A Farinelli, J M Padin, J C Troncoso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONOA Raimondi, S Lonardi, S Murgioni, et al.
Pageof 7